Open AccessAbstract 111: Tumor microenvironment derived NRG1 promotes antiandrogen resistance in prostate cancer
Author(s) -
Zeda Zhang,
Wouter R. Karthaus,
José Maurício Mota,
Ping Mu,
Chao Wu,
Wassim Abida,
Eliot Linton,
Young Sun Lee,
Eugine Lee,
Ninghui Mao,
Elizabeth Adams,
Danielle Choi,
Dana E. Rathkopf,
Brett S. Carver,
Anuradha Gopalan,
Xuejun Jiang,
Philip A. Watson,
Charles L. Sawyers
Publication year - 2019
Publication title -
cancer research
Language(s) - Uncategorized
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2019-111
Subject(s) - antiandrogen , prostate cancer , cancer research , medicine , antiandrogens , flutamide , androgen deprivation therapy , androgen , cancer , prostate , tumor progression , androgen receptor , endocrinology , oncology , hormone